Fundraising FoxOlaregen Therapeutix
New York, US · Founded 2017 · Delaware corporation
Find your way into Olaregen Therapeutix
Sign up to see every warm intro you have to Olaregen Therapeutix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Olaregen Therapeutix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SE
Scott EmmensNamed on SEC filing
WR
Wesley RamjeetNamed on SEC filing
AD
Anthony DolisiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$450K disclosed across 1 round · 2018
▶$450KraisedSep 2018 · 1 investors · BiotechnologyRule 506(b)
▶$450KraisedSep 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott EmmensExecutive Officer
- Wesley RamjeetExecutive Officer, Director
- Anthony DolisiExecutive Officer
- Offering amount
- $1.2M
- Amount sold
- $450K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Olaregen Therapeutix raised?
- Olaregen Therapeutix has disclosed $450K raised across 1 round.
- Where is Olaregen Therapeutix headquartered?
- Olaregen Therapeutix is headquartered in New York, US.